当前位置: X-MOL 学术Immunopharmacol. Immunotoxicol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells.
Immunopharmacology and Immunotoxicology ( IF 3.3 ) Pub Date : 2020-02-12 , DOI: 10.1080/08923973.2020.1725040
Asuman Deveci Ozkan 1 , Suleyman Kaleli 1 , Hacer Ilke Onen 2 , Mehmet Sarihan 3 , Gamze Guney Eskiler 1 , Aysel Kalayci Yigin 4 , Mehmet Akdogan 5
Affiliation  

Background: Toll-like receptors (TLRs) are often expressed in natural immune cells as well as in tumor cells. TLR4 exhibits both tumor promoting and tumor-suppressing roles and higher TLR9 expression is an important marker of poor prognosis in prostate cancer (PCa). Nobiletin (NOB) is an O-methylated flavonoid and NOB has been proven to have anti-cancer effect in PCa cells. However, there is no study in the literature investigating the potential anti-inflammatory effects of NOB on the TLR signaling pathways in cancer. Therefore, we aimed to explore the potential anti-inflammatory effects of NOB on the TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in different types of PCa cell lines, for the first time.Material and methods: In the current study, the cytotoxic effect of NOB PC-3 (hormone-independent and metastatic) and LNCaP cells (hormone-dependent) was evaluated by WST-1 assay. Furthermore, the inhibitory effects of NOB on TLR4/TRIF/IRF3 and TLR9/IRF7signaling pathway were determined by RT-PCR, western blotting and ELISA analysis.Results: NOB demonstrated an inhibitory effect on PCa cell growth and LNCaP cells were more sensitive to NOB than PC-3 cells due to androjen receptor status. Furthermore, NOB alone could suppress TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways through the downregulation of their associated pathways (mRNA and related protein levels) and the release of IFN-α and IFN-β compared to LPS or CpG-ODN stimulated PCa cells.Conclusions: NOB potentially inhibited TLR4 and TL9-dependent signaling pathway in PCa cells. However, the efficacy of NOB was different in PCa cells due to the hormone status and aggressive features.

中文翻译:

诺比列汀对前列腺癌细胞中TLR4 / TRIF / IRF3和TLR9 / IRF7信号通路的抗炎作用。

背景:Toll样受体(TLR)通常在天然免疫细胞以及肿瘤细胞中表达。TLR4同时具有促进肿瘤和抑制肿瘤的作用,而较高的TLR9表达是前列腺癌(PCa)预后不良的重要标志。Nobiletin(NOB)是一种O-甲基化的类黄酮,NOB已被证明对PCa细胞具有抗癌作用。但是,没有文献研究NOB对癌症中TLR信号通路的潜在抗炎作用。因此,我们旨在首次探索NOB对不同类型PCa细胞系中TLR4 / TRIF / IRF3和TLR9 / IRF7信号通路的潜在抗炎作用。材料与方法:在本研究中,通过WST-1分析评估NOB PC-3(激素依赖性和转移性)和LNCaP细胞(激素依赖性)的细胞毒性作用。此外,通过RT-PCR,western blotting和ELISA分析,确定了NOB对TLR4 / TRIF / IRF3和TLR9 / IRF7信号通路的抑制作用。结果:NOB对PCa细胞的生长具有抑制作用,而LNCaP细胞对NOB的敏感性更高。由于雄激素受体状态,PC-3细胞比PC-3细胞多。此外,与LPS或CpG-ODN刺激相比,单独的NOB可以通过下调其相关途径(mRNA和相关蛋白水平)以及释放IFN-α和IFN-β来抑制TLR4 / TRIF / IRF3和TLR9 / IRF7信号传导途径。结论:NOB可能抑制PCa细胞中TLR4和TL9依赖性信号通路。然而,
更新日期:2020-04-20
down
wechat
bug